July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase

Omega reveals venture tally
Omega Therapeutics Inc. announced it has raised $85 million since its 2016 launch by Flagship Pioneering to support development of therapies targeting chromatin structures. The funding includes a series A round from Flagship and a series B round led by the firm with participation by other investors. Other investors and details

Read the full 542 word article

How to gain access

Continue reading with a
two-week free trial.